- Home
- IMA vs ADBT Comparison
IMA vs ADBT Comparison
Compare IMA & ADBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMA | ADBT |
|---|---|---|
| Founded | 2019 | 2017 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 55.0M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IMA | ADBT |
|---|---|---|
| Price | $4.11 | $0.10 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 12.1K | ★ 4.0M |
| Earning Date | 11-20-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.86 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.88 | $0.09 |
| 52 Week High | $8.84 | $4.99 |
Technical Indicators
Market Signals| Indicator | IMA | ADBT |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 6.46 |
| Support Level | $3.91 | $0.10 |
| Resistance Level | $6.13 | $0.13 |
| Average True Range (ATR) | 0.22 | 0.01 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 39.48 | 7.43 |
Price Performance
Historical ComparisonAbout IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
About ADBT Advasa Holdings Inc. Common Stock
Advasa Holdings Inc is a financial technology and services company that offers a suite of financial services and solutions. Its earned wage access (EWA) service, named 'FUKUPE', provides employees with real-time access to their earned wages through cashless receipts and settlements that integrate seamlessly with wallets, cards, and bank accounts. The company also licenses its EWA technology portfolio and offers OEM (original equipment manufacturer) services. The company generates the majority of revenue from the provision of software maintenance services. Geographically, the company operates only in Japan.